Martin Shkreli Says His Twitter Account was Hacked

KaloBios Pharma (KBIO) Trading Halt Remains in Effect Despite CEO Firing Update

Despite today's firing of CEO, Martin Shkreli, KaloBios Pharma (NASDAQ: KBIO) shares remain halted on the NASDAQ exchange with a T12 halt... More

KaloBios Pharma (KBIO) Terminates CEO Martin Shkreli

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) announced that on December 17, 2015, Martin Shkreli was terminated as Chief Executive Officer of the Company and resigned from his position as a member of the board of directors. In addition, on December 17, 2015, Tony Chase resigned from... More

Martin Shkreli attributes arrest to drug-price hikes: WSJ

(Reuters) - Martin Shkreli, the pharmaceutical entrepreneur facing U.S. charges of securities fraud, has said he had been the target of legal authorities for his much-criticized drug-price hikes and his over-the-top public persona, the Wall Street Journal reported.

Shkreli, who was arrested on Thursday and released soon after on a $5 million bond, has been charged for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund MSMB Capital Management and Retrophin Inc, a company he headed... More

UPDATE: Turing Pharma CEO Shkreli Resigns; Co. Remains Committed to Affordable Daraprim, Vecamyl Access

(Updated - December 18, 2015 12:43 PM EST)

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, today announced the resignation of Martin Shkreli from the position of Chief Executive Officer and the appointment of Ron Tilles to the position of Interim Chief Executive Officer.

Mr. Tilles will continue to serve as... More

Martin Shkreli 'essentially ran his companies like a ponzi scheme' - US Attorney

Martin Shkreli "essentially ran his companies like a ponzi scheme" - US Attorney

KaloBios (KBIO) CEO Martin Shkreli Arrested for Fraud; Prosecutors Probing Retrophin Claims

(Updated - December 17, 2015 6:38 AM EST)

Martin Shkreli, CEO reviled for drug price gouging, arrested for fraud.

UPDATE - Shkreli was recent named CEO at KaloBios Pharma (Nasdaq: KBIO). He is also CEO at Turing Pharma, where he jacked the... More